glp-1 guidelines for weight loss is only severely obese people. The clinical say otherwise. You may qualify for GLP-1 medication if you have a BMI of 30 or higher, OR a BMI of 27 GLP-1 and GIP–GLP-1 therapies benefits

This trial included four active treatment arms: in two arms, the berobenatide doses were not escalated (0.4 mg and 0.6 mg), and in the other two arms, doses were escalated from 0.4 mg to 1.2 mg or 1.6 mg

GLP-1: Diabetes and Weight Loss Drug Side Effects (Ozempic, Face, and More). Harvard Health

Last reviewed: 02 Jul 2026 Sources Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1

Do GLP-1 medications increase thyroid cancer risk

These products are 100% effective

In people with type 2 diabetes, the body's cells are resistant to the effects of insulin, the body does not produce enough insulin, or both